Profiling the Variation of Microbiome Along the Intestinal Tract Based on Sampling Capsule Endoscopy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorChanghai Hospital

About this trial

Intestinal flora and metabolites are associated with multiple systemic diseases. Current approaches for acquiring information regarding microbiota/metabolites have limitations. We aimed to develop a precise sampling capsule endoscopy (SCE) for the convenient, non-invasive, and accurate acquisition of digestive bioinformation for disease diagnosis and evaluation. The SCE was used for sampling jejunum, ileum, and colon content in healthy volunteers. The GI liquid was then used for microbiome profiling and metabolomics profiling. In this study, we aimed to describe the characteristics and functions of key microflora in the whole intestinal microenvironment of healthy volunteers.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Male or female, age ≥18 years and ≤80 years;

American Society of Anesthesiologists (ASA) physical health risk level 1;

Good overall health, no clinically significant medical history;

No clinically significant signs were found in the physical examination;

Disqualifiers

Patients with digestive tract diseases such as cancer, inflammatory bowel disease, achalasia, esophageal diverticulum, etc.;

Patients who have participated in other clinical trials within three months or are currently participating in other clinical trials;

Patients currently use medication for other diseases or plan to use medication for treatment;

Patients who have used antibiotics within three months;

Trial design

Design model

Single group

Treatments tested in this trial

  • sampling capsule endoscopy

    Device

    Healthy volunteers swallowed SCEs to collect intestinal fluids in different intestinal areas. When SCEs excreted, the fluids inside SCEs would be collected for microbiome and metabolome analysis.

Treatment groups

40 Participants
are divided into 1 treatment group
Group A: Healthy volunteersOther 1 intervention

Trial outcomes

Primary outcomes

1

The feasibility of sampling capsule endoscopy system in collecting fluids from different intestinal segments in healthy volunteers

The total successful rate of SCE in sampling fluids in intestinal segments. A successful sampling procedure conducted by SCE was defined when the following conditions were met simultaneously: 1) accurately recognization of target intestinal areas. 2) the intestinal liquid can be successfully collected in the sampling chamber.

Time frame
two weeks

Secondary outcomes

1

Standard gastrointestinal preparation procedure

To select the best standard gastrointestinal preparation procedure which makes the visualization score under SCE graded as the best (on a scale of 1 to 5; 1, the worst; 5, the best) .

Time frame
two week
2

Sampling time

The total time for sampling intestinal fluids of a SCE.

Time frame
two weeks
3

Sampling volume

The overall volume of samples obtained by a SCE during a single examination.

Time frame
two weeks
4

Number of sampling times

Times we tried to sample during a single SCE examination.

Time frame
two weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: